These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38802404)

  • 21. Analysis of population-specific pharmacogenomic variants using next-generation sequencing data.
    Ahn E; Park T
    Sci Rep; 2017 Sep; 7(1):8416. PubMed ID: 28871186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing.
    Zhou Y; Koutsilieri S; Eliasson E; Lauschke VM
    Basic Clin Pharmacol Toxicol; 2022 Dec; 131(6):452-464. PubMed ID: 35971800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
    Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM
    Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.
    Choi J; Tantisira KG; Duan QL
    Pharmacogenomics J; 2019 Apr; 19(2):127-135. PubMed ID: 30214008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic Variation among Pharmacogenes in the Sardinian Population.
    Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; Orrù S; Schlessinger D; Cucca F; Floris M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
    Nguyen TT; Pearson RA; Mohamed ME; Schladt DP; Berglund D; Rivers Z; Skaar DJ; Wu B; Guan W; van Setten J; Keating BJ; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
    J Clin Pharm Ther; 2020 Dec; 45(6):1457-1465. PubMed ID: 32662547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomic Biomarkers: an FDA Perspective on Utilization in Biological Product Labeling.
    Schuck RN; Grillo JA
    AAPS J; 2016 May; 18(3):573-7. PubMed ID: 26912182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applying Multiplex Assays to Understand Variation in Pharmacogenes.
    Chiasson M; Dunham MJ; Rettie AE; Fowler DM
    Clin Pharmacol Ther; 2019 Aug; 106(2):290-294. PubMed ID: 31145826
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeted next generation sequencing as a tool for precision medicine.
    Gulilat M; Lamb T; Teft WA; Wang J; Dron JS; Robinson JF; Tirona RG; Hegele RA; Kim RB; Schwarz UI
    BMC Med Genomics; 2019 Jun; 12(1):81. PubMed ID: 31159795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics.
    Santos M; Niemi M; Hiratsuka M; Kumondai M; Ingelman-Sundberg M; Lauschke VM; Rodríguez-Antona C
    Genet Med; 2018 Jun; 20(6):622-629. PubMed ID: 29261188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole-genome sequences.
    Sivadas A; Salleh MZ; Teh LK; Scaria V
    Pharmacogenomics J; 2017 Oct; 17(5):461-470. PubMed ID: 27241059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
    Reizine NM; Danahey K; Truong TM; George D; House LK; Karrison TG; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH
    Cancer; 2022 Apr; 128(8):1649-1657. PubMed ID: 35090043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large-scale integration of heterogeneous pharmacogenomic data for identifying drug mechanism of action.
    Luo Y; Wang S; Xiao J; Peng J
    Pac Symp Biocomput; 2018; 23():44-55. PubMed ID: 29218868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and functional validation of novel pharmacogenomic variants using a next-generation sequencing-based approach for clinical pharmacogenomics.
    Siamoglou S; Koromina M; Hishinuma E; Yamazaki S; Tsermpini EE; Kordou Z; Fukunaga K; Chantratita W; Zhou Y; Lauschke VM; Mushiroda T; Hiratsuka M; Patrinos GP
    Pharmacol Res; 2022 Feb; 176():106087. PubMed ID: 35033648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.
    Sahana S; Sivadas A; Mangla M; Jain A; Bhoyar RC; Pandhare K; Mishra A; Sharma D; Imran M; Senthivel V; Divakar MK; Rophina M; Jolly B; Batra A; Sharma S; Siwach S; Jadhao AG; Palande NV; Jha GN; Ashrafi N; Mishra PK; Vidhya AK; Jain S; Dash D; Kumar NS; Vanlallawma A; Sarma RJ; Chhakchhuak L; Kalyanaraman S; Mahadevan R; Kandasamy S; Devi P; Rajagopal RE; Ramya JE; Devi PN; Bajaj A; Gupta V; Mathew S; Goswami S; Prakash S; Joshi K; Kumla M; Sreedevi S; Gajjar D; Soraisham R; Yadav R; Devi YS; Gupta A; Mukerji M; Ramalingam S; Binukumar BK; Sivasubbu S; Scaria V
    Pharmacogenomics; 2021 Jul; 22(10):603-618. PubMed ID: 34142560
    [No Abstract]   [Full Text] [Related]  

  • 36. Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations.
    Al-Mahayri ZN; Patrinos GP; Wattanapokayakit S; Iemwimangsa N; Fukunaga K; Mushiroda T; Chantratita W; Ali BR
    Sci Rep; 2020 Dec; 10(1):21310. PubMed ID: 33277594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies.
    Samwald M; Miñarro Giménez JA; Boyce RD; Freimuth RR; Adlassnig KP; Dumontier M
    BMC Med Inform Decis Mak; 2015 Feb; 15():12. PubMed ID: 25880555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualizing pharmacogenomic test results in the context of the microbiome.
    Haga SB
    Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing.
    Lee YM; Danahey K; Knoebel RW; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):23-30. PubMed ID: 30531378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
    Chanfreau-Coffinier C; Hull LE; Lynch JA; DuVall SL; Damrauer SM; Cunningham FE; Voight BF; Matheny ME; Oslin DW; Icardi MS; Tuteja S
    JAMA Netw Open; 2019 Jun; 2(6):e195345. PubMed ID: 31173123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.